세계의 유전체 엔지니어링 시장 : 기술, 용도, 최종 사용자별 예측(2025-2030년)

The Genome Engineering Market was valued at USD 6.33 billion in 2023, expected to reach USD 7.32 billion in 2024, and is projected to grow at a CAGR of 15.68%, to USD 17.57 billion by 2030.

Genome engineering, a transformative area within biotechnology, encompasses techniques and technologies developed to manipulate an organism's genetic material. Its scope includes methods such as CRISPR-Cas9, TALENs, and ZFNs, which have broadened possibilities in areas like gene therapy, agriculture, and synthetic biology. The necessity of genome engineering lies in its potential to address pervasive challenges such as genetic disorders, crop resilience, and the development of biofuels. Its applications are diverse, covering therapeutic uses like eradicating genetic diseases, enhancing agricultural productivity through genetically modified crops, and advancing personalized medicine by customizing treatments based on genomic data.

The end-use scope spans healthcare, agriculture, pharmaceuticals, and industrial biotechnology. Key growth influencers in this market include advancements in genome editing technologies, increasing funding from government bodies and private institutions, and rising demand for biotechnological innovations to improve health outcomes and food security. Emerging opportunities are particularly visible in gene therapy and precision medicine, with markets poised to benefit significantly from breakthroughs that allow for precise genetic modifications. Companies are advised to invest in R&D, focusing on the development of improved, efficient, and cost-effective genome editing tools while keeping abreast of regulatory frameworks and ethical considerations.

However, the market faces limitations and challenges, including ethical concerns around genetic manipulation and stringent regulatory requirements that can hinder rapid commercialization. High costs associated with genome editing procedures and limited technical expertise in some regions also pose significant hurdles. Innovation and research should target overcoming these difficulties, with promising areas including advancements in delivery mechanisms to improve efficiency and reduce costs, exploring novel applications in microbiome engineering, and developing eco-friendly gene drives for pest control.

Overall, the genome engineering market, characterized by rapid growth and technological advancements, presents significant opportunities but requires strategic navigation of ethical and regulatory landscapes to realize its full potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genome Engineering Market

The Genome Engineering Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing demand for synthetic gene in biotechnology sector
  • Rising implementation of CRISPR genome editing technology
  • Increasing adoption in diagnostics sector worldwide
• Market Restraints
  • High equipment/systems costs in genome engineering
• Market Opportunities
  • Constant technological developments in gene-editing tools
  • Emerging application in personalized medicine
• Market Challenges
  • Issues associaetd with genetic engineering

Porter's Five Forces: A Strategic Tool for Navigating the Genome Engineering Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genome Engineering Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genome Engineering Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genome Engineering Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genome Engineering Market

A detailed market share analysis in the Genome Engineering Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genome Engineering Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genome Engineering Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genome Engineering Market

A strategic analysis of the Genome Engineering Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genome Engineering Market, highlighting leading vendors and their innovative profiles. These include Bluebird Bio, Inc., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., GenScript Biotech Corporation, Horizon Discovery Group PLC, Intellia Therapeutics, Inc., Lonza Group AG, Merck & Co., Inc., New England Biolabs, Origene Technologies, Precision BioSciences, Inc., Sangamo Therapeutics, Inc., Thermo Fisher Scientific Inc., and Transposagen Biopharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Genome Engineering Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Clustered Regularly Interspaced Short Palindromic Repeats, Transcription Activator-like Effector Nuclease, and Zinc Finger Nuclease.
• Based on Application, market is studied across Animal Genetic Engineering, Cell Line Engineering, and Plant Genome Engineering.
• Based on End-User, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing demand for synthetic gene in biotechnology sector
    • 5.1.1.2. Rising implementation of CRISPR genome editing technology
    • 5.1.1.3. Increasing adoption in diagnostics sector worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. High equipment/systems costs in genome engineering
  • 5.1.3. Opportunities
    • 5.1.3.1. Constant technological developments in gene-editing tools
    • 5.1.3.2. Emerging application in personalized medicine
  • 5.1.4. Challenges
    • 5.1.4.1. Issues associaetd with genetic engineering
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Genome Engineering Market, by Technology

• 6.1. Introduction
• 6.2. Clustered Regularly Interspaced Short Palindromic Repeats
• 6.3. Transcription Activator-like Effector Nuclease
• 6.4. Zinc Finger Nuclease

7. Genome Engineering Market, by Application

• 7.1. Introduction
• 7.2. Animal Genetic Engineering
• 7.3. Cell Line Engineering
• 7.4. Plant Genome Engineering

8. Genome Engineering Market, by End-User

• 8.1. Introduction
• 8.2. Academic & Government Research Institutes
• 8.3. Biotechnology & Pharmaceutical Companies
• 8.4. Contract Research Organizations

9. Americas Genome Engineering Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Genome Engineering Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Genome Engineering Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Bluebird Bio, Inc.
• 2. CRISPR Therapeutics AG
• 3. Danaher Corporation
• 4. Editas Medicine, Inc.
• 5. GenScript Biotech Corporation
• 6. Horizon Discovery Group PLC
• 7. Intellia Therapeutics, Inc.
• 8. Lonza Group AG
• 9. Merck & Co., Inc.
• 10. New England Biolabs
• 11. Origene Technologies
• 12. Precision BioSciences, Inc.
• 13. Sangamo Therapeutics, Inc.
• 14. Thermo Fisher Scientific Inc.
• 15. Transposagen Biopharmaceuticals, Inc.